Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up time frame: day 0, day 14, day 28, day 56
Awards & highlights
No Placebo-Only Group
Summary
This trial will test how well text messages can help people form healthy habits.
Who is the study for?
This trial is for individuals with social anxiety, as indicated by a score greater than 29 on the Social Phobia Inventory. Participants must have been on stable psychotropic medications for at least four weeks and should not be currently receiving psychotherapy specifically for social anxiety.
What is being tested?
The study is testing a text message-based intervention designed to reduce safety behaviors that people with social anxiety might rely on. It's being compared to an active control group to measure its effectiveness in managing symptoms of social anxiety.
What are the potential side effects?
Since this trial involves behavioral interventions through text messaging rather than medication or medical procedures, traditional physical side effects are not expected. However, participants may experience increased anxiety or discomfort when reducing their safety behaviors.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ time frame: day 0, day 14, day 28, day 56
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~time frame: day 0, day 14, day 28, day 56
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Social Phobia Inventory (SPIN)
Secondary study objectives
Change in Center For Epidemiological Studies Depression Scale, Ten Item Version (CESD-10)
Change in Self-Beliefs Related to Social Anxiety Scale (SBSA)
Change in Subtle Avoidance Frequency Examination (SAFE) scale
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental: Safety Behavior FadingExperimental Treatment1 Intervention
This treatment lasts a total of 28 days. Participants will be asked to identify common safety behaviors related to social anxiety. For the next 14 days, participants will receive instructions to fade out these behaviors. After 14 days, participants will be asked to re-select their target safety behaviors and continue to reduce them over the next two weeks.
Group II: Unhealthy Behavior FadingActive Control1 Intervention
This treatment lasts a total of 28 days. Participants will be asked to identify common unhealthy behaviors related to social anxiety. For the next 14 days, participants will receive instructions to fade out these behaviors. After 14 days, participants will be asked to re-select their target unhealthy behaviors and continue to reduce them over the next two weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Safety Behavior Fading for Social Anxiety
2021
N/A
~160
Find a Location
Who is running the clinical trial?
Florida State UniversityLead Sponsor
220 Previous Clinical Trials
36,331 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger